Information Provided By:
Fly News Breaks for June 12, 2019
CTHR
Jun 12, 2019 | 07:52 EDT
Roth Capital analyst Dave King started coverage of Charles & Colvard with a Buy rating and $2.50 price target. The analyst believes Charles & Colvard is positioned to benefit from the rising popularity of lab-created gemstones, which are increasingly viewed as a more ethical and affordable alternative to mined diamonds. King points out that the company has successfully transitioned to more of an e-commerce delivery model and sees opportunity to increase digital marketing to drive further topline gains.
News For CTHR From the Last 2 Days
There are no results for your query CTHR